| Frequency of familial occurrence in 164 patients with allergic bronchopulmonary aspergillosis A Shah, J Kala, S Sahay, C Panjabi Annals of Allergy, Asthma & Immunology 101 (4), 363-369, 2008 | 54 | 2008 |
| Bronchial anthracofibrosis and tuberculosis presenting as a middle lobe syndrome J Kala, S Sahay, A Shah Primary Care Respiratory Journal 17 (1), 51-55, 2008 | 52 | 2008 |
| Allergic bronchopulmonary aspergillosis with hilar adenopathy in a 42-month-old boy. A Shah, J Kala, S Sahay Pediatric pulmonology 42 (8), 747-748, 2007 | 23 | 2007 |
| Eruptive xanthoma J Kala, EN Mostow New England Journal of Medicine 366 (9), 835-835, 2012 | 15 | 2012 |
| Magnesium: an overlooked electrolyte J Kala, A Abudayyeh The Journal of emergency medicine 52 (5), 741-743, 2017 | 14 | 2017 |
| Radiation Induced kidney Injury J Kala Journal of Onconephrology 3 (3), 160-167, 2019 | 13 | 2019 |
| Onconephrology J Kala, KW Finkel Critical care clinics 37 (2), 365-384, 2021 | 10 | 2021 |
| Selinexor-associated hyponatremia: single-center, real-world data J Kala, O Mamlouk, KD Jhaveri Kidney International 98 (3), 789-791, 2020 | 10 | 2020 |
| Nephrotoxicity from molecularly targeted chemotherapeutic agents J Kala, LA Salman, AS Geara, H Izzedine Advances in Chronic Kidney Disease 28 (5), 415-428. e1, 2021 | 7 | 2021 |
| Case Report: Successful treatment of late-onset immune checkpoint inhibitor-associated membranous nephropathy in a patient with advanced renal cell carcinoma P Ratanasrimetha, VD Reddy, J Kala, A Tchakarov, WF Glass, P Msaouel, ... Frontiers in immunology 13, 898811, 2022 | 5 | 2022 |
| Unique case of ANCA-negative pauci-immune necrotizing glomerulonephritis with diffuse alveolar hemorrhage, potentially associated with midostaurin JD Pankow, G Richard-Carpentier, NG Daver, WF Glass, J Kala CEN case reports 9, 147-151, 2020 | 5 | 2020 |
| Lymphoma Masquerading as an Ear Mass KN Cuartas, NR Wilson, J Kala Cureus 13 (3), 2021 | 2 | 2021 |
| Pembrolizumab-Induced Acral Vasculitis B Yohannan, T Truly, J Kala, SH Jafri Journal of Immunotherapy 46 (3), 107-110, 2023 | 1 | 2023 |
| Influenza-induced thrombotic microangiopathy in a patient with cancer on proteasome inhibitor: a diagnostic dilemma CD Hamad, ZC Hoelscher, A Tchakarov, J Kala CEN Case Reports 11 (3), 321-327, 2022 | 1 | 2022 |
| Renal lymphomatous infiltration by mantle cell lymphoma: treatment with chemoradiation and initiation of angiotensin converting enzyme (ACE) inhibitor for renal protection EP Damron, JR Gunther, J Kala Journal of Onco-Nephrology 5 (3), 183-187, 2021 | 1 | 2021 |
| An extra year of Onco-Nephrology fellowship training is required for the subspecialty: PRO S Latcha, J Kala, A Kitchlu, N Leung Journal of Onco-Nephrology 5 (1), 31-34, 2021 | 1 | 2021 |
| Renal Replacement Therapy in Critically Ill Cancer Patients JK Kevin W. Finkel In: Nates J., Price K. (eds). Oncologic Critical Care 1, 1-12, 2019 | 1* | 2019 |
| TO DETERMINE THE FREQUENCY AND SEVERITY OF ADVERSE DRUG REACTIONS (ADR) TO SECOND LINE ANTITUBERCULOUS THERAPY (ATT) IN PATIENTS WITH MULTIDRUG-RESISTANT TUBERCULOSIS (MDR-TB) J Kala, AK Bhatnagar, JN Banavaliker Chest 134 (4), 131P, 2008 | 1 | 2008 |
| Risk Factors for Severe Hypertension and Proteinuria After Treatment With Vascular Endothelial Growth Factor Signaling Pathway Inhibitors Among Patients With Cancer PE Hanna, RK Anumolu, SS Motwani, KL Chen, N Katz-Agranov, ... Kidney International Reports, 2024 | | 2024 |
| Spontaneous Page kidney from ruptured renal angiomyolipoma N Neela, H Taha, J Kala Baylor University Medical Center Proceedings 34 (6), 689-690, 2021 | | 2021 |
